Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biomedical Engineering,Biomaterials,Bioengineering,Biotechnology
Reference331 articles.
1. Delivery methods for CRISPR/Cas9 gene editing in crustaceans;Xu;Mar. Life Sci. Tech.,2020
2. Cancer statistics, 2022, CA;Siegel;Cancer J. Clin.,2022
3. Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation;Na;NPJ Breast Cancer,2019
4. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling;Huang;Nat. Commun.,2021
5. New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin;Ciocan-Cȃrtiţă;Mol. Cell. Biochem.,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024;Drug Delivery and Translational Research;2024-09-06
2. Precision arrows: Navigating breast cancer with nanotechnology siRNA;International Journal of Pharmaceutics;2024-09
3. Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast Cancer;Advanced Healthcare Materials;2024-08-12
4. Advanced gene therapy system for the treatment of solid tumour: A review;Materials Today Bio;2024-08
5. Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment;International Journal of Pharmaceutics;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3